FR2034467A1 - - Google Patents

Info

Publication number
FR2034467A1
FR2034467A1 FR7001029A FR7001029A FR2034467A1 FR 2034467 A1 FR2034467 A1 FR 2034467A1 FR 7001029 A FR7001029 A FR 7001029A FR 7001029 A FR7001029 A FR 7001029A FR 2034467 A1 FR2034467 A1 FR 2034467A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7001029A
Other versions
FR2034467B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2034467A1 publication Critical patent/FR2034467A1/fr
Application granted granted Critical
Publication of FR2034467B1 publication Critical patent/FR2034467B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7001029A 1969-01-13 1970-01-13 Expired FR2034467B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB193569 1969-01-13

Publications (2)

Publication Number Publication Date
FR2034467A1 true FR2034467A1 (fr) 1970-12-11
FR2034467B1 FR2034467B1 (fr) 1974-04-12

Family

ID=9730621

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7001029A Expired FR2034467B1 (fr) 1969-01-13 1970-01-13

Country Status (5)

Country Link
CA (1) CA948642A (fr)
CH (1) CH507253A (fr)
DE (1) DE2000210A1 (fr)
FR (1) FR2034467B1 (fr)
GB (1) GB1297261A (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10130504B4 (de) 2001-06-25 2005-02-03 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20030224006A1 (en) 2002-03-01 2003-12-04 Zaworotko Michael J. Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
EP1515703A1 (fr) 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Compositions pharmaceutiques a dissolution amelioree
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen

Also Published As

Publication number Publication date
CH507253A (fr) 1971-05-15
CA948642A (en) 1974-06-04
FR2034467B1 (fr) 1974-04-12
GB1297261A (fr) 1972-11-22
DE2000210A1 (de) 1970-07-23

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU429630B2 (fr)
AU450150B2 (fr)
CS150297B2 (fr)
FR2034467B1 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
CS149916B2 (fr)
AU5113869A (fr)
AU442322B2 (fr)
AU442538B2 (fr)
AU442535B2 (fr)
AU428131B2 (fr)
AU470661B1 (fr)
AU442380B2 (fr)
AU442357B2 (fr)
AU5109569A (fr)
AU4949169A (fr)
CS148839B1 (fr)
AU5598769A (fr)
AU5079269A (fr)
AU4923469A (fr)
AU5077469A (fr)
AU480213A (fr)
BE738203A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse